Vikrant Shrotriya, Managing Director of Novo Nordisk India, said that Ozempic is not a 'party drug' but works with diet and ...

The FDA recently announced that Novo Nordisk’s semaglutide GLP-1 medication (Ozempic and Wegovy) is no longer in short supply ...

Digital was going to transform the shape of WeightWatchers...until it didn't. So what's up next? AI is in the mix inevitably, ...

While GLP-1 drugs are currently available in the market, the Food and Drug Administration (FDA) had declared a shortage of semaglutide supply since 2022 after its popularity skyrocketed following news ...

The specialty pharmacy business may be the most attractive part of Walgreens as rumors swirl the company will be taken over ...

The weight loss drug market is booming, with GLP-1 medications projected to hit $100 billion by 2030. These drugs, which help ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

The Cleveland Clinic also warns against buying into the “nature’s Ozempic” hype but says the supplement could also aid in ...

They dance in kitchens and in meadows frothy with flowers. They dance at weddings. They dance while fireworks bloom in dark ...

The start-up Loyal developed a pill to extend dogs’ lifespan that has been recognized by the FDA as having “reasonable ...

While many industry players and observers have high hopes for the EPIC Act, some say budgetary headwinds could make it ...